Shaperon Inc.
Develops inflammasome inhibitors & nanobodies for inflammatory diseases and cancer.
378800 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 강남구 자곡로 174-10 강남에이스타워 606호(자곡동), 서울특별시
- Website:
- https://www.shaperon.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Shaperon Inc. is a clinical-stage biotechnology company focused on developing novel therapeutics for inflammatory diseases and cancer. The company specializes in creating innovative inflammasome inhibitors, utilizing a unique mechanism of action involving GPCR19-P2X7 modulation to suppress immune responses. Its development pipeline targets conditions such as atopic dermatitis and other immune-mediated inflammatory disorders. In addition to small molecules, Shaperon develops nanobody therapeutics for cancer immunotherapy, leveraging proprietary immunized libraries and high-throughput screening technologies. Founded in 2008, the company completed a successful initial public offering in October 2022.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Shaperon Inc. and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-09-16 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 86.0 KB | |
| 2025-09-16 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 25.0 KB | |
| 2025-09-16 00:00 |
Share Issue/Capital Change
유상증자1차발행가액결정 (주주배정후 실권주 일반공모)
|
Korean | 7.6 KB | |
| 2025-09-16 00:00 |
Share Issue/Capital Change
[기재정정]주요사항보고서(유상증자결정)
|
Korean | 40.4 KB | |
| 2025-09-16 00:00 |
Registration Form
[발행조건확정]증권신고서(지분증권)
|
Korean | 435.2 KB | |
| 2025-09-16 00:00 |
Prospectus
투자설명서
|
Korean | 2.7 MB | |
| 2025-09-16 00:00 |
Share Issue/Capital Change
권리락 (유상증자)
|
Korean | 3.5 KB | |
| 2025-09-12 00:00 |
Director's Dealing
임원ㆍ주요주주특정증권등거래계획보고서
|
Korean | 42.6 KB | |
| 2025-09-01 00:00 |
Registration Form
[기재정정]증권신고서(지분증권) (2025.10)
|
Korean | 3.2 MB | |
| 2025-08-18 00:00 |
Share Issue/Capital Change
주요사항보고서(유상증자결정)
|
Korean | 32.0 KB | |
| 2025-08-18 00:00 |
Registration Form
증권신고서(지분증권) (2025.10)
|
Korean | 2.5 MB | |
| 2025-08-14 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 1.4 MB |
Automate Your Workflow. Get a real-time feed of all Shaperon Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Shaperon Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
